Molecular Imaging and the PD-L1 Pathway: From Bench to Clinic
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.698425
Abstract: Programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1) inhibitors target the important molecular interplay between PD-1 and PD-L1, a key pathway contributing to immune evasion in the tumor microenvironment (TME). Long-term clinical benefit has… read more here.
Keywords: imaging pathway; pet; bench clinic; expression ... See more keywords